We are live on ! Find out more
PAVM icon

PAVmed
PAVM

32 hedge funds and large institutions have $2.95M invested in PAVmed in 2025 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

302% more capital invested

Capital invested by funds: $735K → $2.95M (+$2.22M)

200% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 2

133% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 3

14% more funds holding

Funds holding: 28 → 32 (+4)

0% more ownership

Funds ownership: 0.24% → 0.24% (+0%)

Holders
32
Holders Change
+4
Holders Change %
+14.29%
% of All Funds
0.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
7
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$62.9K
2
Jane Street
Jane Street
New York
+$49.4K
3
SWGC
Summit Wealth Group (Colorado)
Colorado
+$21.3K
4
VF
Virtu Financial
New York
+$19.3K
5
Northern Trust
Northern Trust
Illinois
+$17.2K

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$3.91K
2
Raymond James Financial
Raymond James Financial
Florida
-$1.49K
3
TRCT
Tower Research Capital (TRC)
New York
-$59
4
MYIA
Mount Yale Investment Advisors
Colorado
-$20
5
Bank of America
Bank of America
North Carolina
-$15
Name Holding Trade Value Shares
Change 		Change in
Stake
SWGC
1
Summit Wealth Group (Colorado)
Colorado
$2.29M +$21.3K +1,434 New
First Manhattan
2
First Manhattan
New York
$308K – – –
Vanguard Group
3
Vanguard Group
Pennsylvania
$90.2K +$62.9K +4,230 +156%
Jane Street
4
Jane Street
New York
$65.6K +$49.4K +3,321 +189%
Geode Capital Management
5
Geode Capital Management
Massachusetts
$41.8K +$3.91K +263 +9%
BlackRock
6
BlackRock
New York
$31.3K – – –
CAPTRUST Financial Advisors
7
CAPTRUST Financial Advisors
North Carolina
$28K – – –
LPL Financial
8
LPL Financial
California
$23.9K – – –
Northern Trust
9
Northern Trust
Illinois
$20K +$17.2K +1,160 +297%
VF
10
Virtu Financial
New York
$17K +$19.3K +1,299 New
OWP
11
Obermeyer Wealth Partners
Colorado
$9.27K – – –
State Street
12
State Street
Massachusetts
$9.03K – – –
XT
13
XTX Topco
Cayman Islands
$5.33K +$6.09K +410 New
XF
14
XML Financial
Maryland
$4.34K – – –
Carson Wealth (CWM LLC)
15
Carson Wealth (CWM LLC)
Nebraska
$3K – – –
Morgan Stanley
16
Morgan Stanley
New York
$2.17K – – –
TRCT
17
Tower Research Capital (TRC)
New York
$1.89K -$59 -4 -3%
Wells Fargo
18
Wells Fargo
California
$709 +$104 +7 +15%
UBS Group
19
UBS Group
Switzerland
$375 -$3.91K -263 -90%
CIBC Private Wealth Group
20
CIBC Private Wealth Group
Georgia
$360 – – –
AF
21
Allworth Financial
California
$128 – – –
Jones Financial Companies
22
Jones Financial Companies
Missouri
$104 – – –
Bank of America
23
Bank of America
North Carolina
$56 -$15 -1 -20%
SS
24
SBI Securities
Japan
$47 – – –
FDCDDQ
25
Federation des caisses Desjardins du Quebec
Quebec, Canada
$41 – – –
1
2

PAVM Hedge Fund Activity: Q3 2025 in Review

32 of the 7,625 institutional investors tracked by Wall St. Rank reported a position in PAVmed (PAVM) for Q3 2025, worth a combined $2.95M — up 302% from $735K a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new PAVM positions and 2 closed out — a net gain of 4 holders — while 7 added to existing stakes and 3 trimmed.

The largest buyer was Vanguard Group, adding an estimated $62.9K. The largest seller was UBS Group, cutting an estimated $3.91K.

  • 32 institutional investors held PAVmed (PAVM) as of Q3 2025, up from 28 in Q2 2025.
  • Funds reported $2.95M of PAVmed stock for Q3 2025, up 302% quarter-over-quarter.
  • 6 funds opened new PAVmed positions in Q3 2025 and 2 closed out, a net change of +4 holders.
  • The largest PAVmed buyer in Q3 2025 was Vanguard Group, an estimated $62.9K added.
  • The largest PAVmed seller in Q3 2025 was UBS Group, an estimated $3.91K sold.

Based on aggregated 13F filings for Q3 2025.